Combination of nanotechnology and genetic engineering for regulating fatal cancer stemness
The development of chemotherapeutic agents with selective anti-cancer activities is increasingly unattractive due to the emergence of resistance, poor targeting of cancer tissues, and subsequent metastasis.
No hay comentarios:
Publicar un comentario